Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

PACS vs CON: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CON Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

CON Overall Winner 6-Pillar Tally: PACS 2 – 4 CON Matrix Metrics: PACS 4 – 6 CON

As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). PACS carries a Unified Composite Score of 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin).

  • Composite vs. Pillar Nuance: While PACS currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. CON 43.5/100 HOLD), CON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (17.2% vs. 7.4% operating margin) and revenue trajectory (+8.6% vs. +11.5% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PACS vs CON
PACS NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap $6.8B
TTM Revenue $5.71B
Forward P/E 15.3x
Beta / 30D Vol 0.78β · 51% Vol
Unified Composite Score
46.8 / 100 HOLD
Tech 35.0 Fund 48.0 Flow 62.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.2 · SMA20: $48.01 · SMA50: $45.43
CON NYSE Head-to-Head Winner
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
TTM Revenue $2.34B
Forward P/E 22.0x
Beta / 30D Vol 0.52β · 38% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 56
RSI-14: 55.6 · SMA20: $41.80 · SMA50: $38.66

6-Pillar Scorecard Institutional Category Breakdown (PACS 2 – 4 CON)

Columns: Metric · PACS · CON
1. Valuation Multiples PACS
Forward P/E 15.3x 22.0x
Trailing P/E 26.2x 24.5x
PEG Ratio 1.22x N/M
EV / Revenue 1.8x 3.1x
2. Growth & Scale PACS
Revenue Growth (YoY) +11.5% +8.6%
Earnings Growth (YoY) +15.6% +36.4%
TTM Revenue (USD) $5.71B $2.34B
Market Cap $6.8B $5.2B
3. Profitability & Quality CON
Gross Margin 17.8% 29.9%
Operating Margin 7.4% 17.2%
Net Profit Margin 4.9% 9.3%
Return on Equity (ROE) 26.5% 47.2%
4. Balance Sheet & Cash Flow CON
Cash Generation (TTM) $8.2M $257M
Cash Flow Margin 0.1% 11.0%
Net Cash / Leverage $3.29B Net Debt (2.81x D/E) $2.04B Net Debt (4.20x D/E)
Dividend Yield None (0.00%) 0.60%
5. Options & Positioning CON
Options Structure Phase CONSOLIDATION BREAKOUT
Current IV / %ile 46.1% (11th %ile) 269.9% (95th %ile)
Put/Call OI Skew 0.52x (Call-Skewed) 0.79x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat CON
OpEx & R&D Intensity 10.4% of Rev ($593M) 12.7% of Rev ($297M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PACS (4) vs CON (6)
Institutional Metric PACS CON Criterion Row Edge
Market Capitalization
Scale
$6.8B $5.2B Larger Scale PACS
Trailing P/E Ratio
Valuation
26.2x 24.5x Lower Multiple CON
Forward P/E Ratio
Valuation
15.3x 22.0x Lower Multiple PACS
Revenue Growth (YoY)
Growth
+11.5% +8.6% Higher Growth PACS
Operating Margin (TTM)
Profitability
7.4% 17.2% Higher Margin CON
Net Profit Margin
Profitability
4.9% 9.3% Higher Margin CON
Return on Equity (ROE)
Capital Efficiency
26.5% 47.2% Higher ROE CON
52-Week Range Position
Momentum
79% ($14–$52) 91% ($19–$44) Stronger Trend CON
Beta / 30D Volatility
Risk Regime
0.78β · 51% Vol 0.52β · 38% Vol Lower Realized Risk CON
Unified Institutional Score
Composite Signal
46.8 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite PACS
Trailing 12M Revenue (USD)
Operating Scale
$5.71B $2.34B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.8% 29.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.22x PEG · 1.8x EV/Rev N/M PEG · 3.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$8.2M ($3.29B Net Debt (2.81x D/E)) $257M ($2.04B Net Debt (4.20x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CON +12.74 pp
PACS: -8.06% · CON: +4.68%
3M Horizon CON +20.89 pp
PACS: -1.31% · CON: +19.58%
6M Horizon CON +49.56 pp
PACS: +15.68% · CON: +65.24%
1Y Horizon PACS +41.9 pp
PACS: +159.48% · CON: +117.58%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period PACS Revenue CON Revenue PACS Op. Margin CON Op. Margin Margin Leader
FY2022 $2.40B $1.72B 9.6% 15.0% CON
FY2023 $3.11B $1.84B 6.7% 15.6% CON
FY2024 $4.09B $1.90B 3.0% 16.0% CON
FY2025 $5.29B $2.16B 5.9% 15.4% CON

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PACS CONSOLIDATION
83d in phase · OBV NEUTRAL
Current IV 46.1%
IV Percentile 11th %ile
Put/Call OI Skew 0.52x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact PACS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CON BREAKOUT
99d in phase · OBV NEUTRAL
Current IV 269.9%
IV Percentile 95th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $49.00 · IV 47.5%

PACS Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($4,900)

Compare $4,900 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 47.5% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $50 / $55 Bull Call Spread

Buy 1x $50C · Sell 1x $55C · 32d

Net Entry $103 Debit
T+5d @ +5% Move +$65 (+63%)
Max Risk / Buffer $103 Capped
5d Edge & Liquidity 1.1x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $45 / $40 Bull Put Spread

Sell 1x $45P · Buy 1x $40P · 32d

Net Entry $104 Credit
Max Credit / Yield +$104 (+26.3% RoM)
Max Risk / Buffer -10.3% Cushion ($396 Mgn)
5d Edge & Liquidity 73% PoP · Liq C
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $45P / $50-$55C Seagull

Sell 1x $45P · Buy 1x $50/$55C · 32d

Net Entry $47 Credit
T+5d @ +5% Move +$146 (+21.3% RoM)
Max Risk / Buffer -8.2% Put Cushion ($683 Mgn)
5d Edge & Liquidity 1.1x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PACS Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $6.8B market capitalization and 7.4% operating margin.
OpEx & R&D Reinvestment 10.4% of Rev ($593M)
90D Engineering Disclosures 0 Published
CON Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.2B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 12.7% of Rev ($297M)
90D Engineering Disclosures 0 Published

Investor FAQ PACS vs CON Key Questions & Quantitative Answers

As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). PACS carries a Unified Composite Score of 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin). Composite vs. Pillar Nuance: While PACS currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. CON 43.5/100 HOLD), CON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (17.2% vs. 7.4% operating margin) and revenue trajectory (+8.6% vs. +11.5% YoY).

PACS leads the Growth & Scale pillar: PACS posts +11.5% YoY revenue growth and +15.6% YoY earnings growth on $5.71B TTM revenue (17.8% gross margin, 7.4% operating margin), compared with CON at +8.6% YoY revenue growth and +36.4% YoY earnings growth on $2.34B TTM revenue (29.9% gross margin, 17.2% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), PACS cumulative revenue shifted +120.4% while CON shifted +25.6%. In operating R&D and SG&A reinvestment, PACS deploys 10.4% of Rev ($593M) (0 90-day corporate R&D disclosures) versus 12.7% of Rev ($297M) (0 disclosures) for CON.

PACS screens cheaper on headline valuation multiples. PACS trades at 15.3x Forward P/E, 26.2x Trailing P/E, 1.22x PEG, and 1.8x EV/Revenue (0.1% FCF margin), whereas CON trades at 22.0x Forward P/E, 24.5x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (11.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PACS (26.5% ROE) versus CON (47.2% ROE) capital efficiency.

In options market volatility and institutional positioning, PACS carries 46.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.52x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.78β · 51% Vol realized risk). By comparison, CON carries 269.9% implied volatility (95th %ile, Extreme (>80th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (0.52β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.